SG11201706693QA - Methods of treating infertility - Google Patents

Methods of treating infertility

Info

Publication number
SG11201706693QA
SG11201706693QA SG11201706693QA SG11201706693QA SG11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA SG 11201706693Q A SG11201706693Q A SG 11201706693QA
Authority
SG
Singapore
Prior art keywords
methods
treating infertility
infertility
treating
Prior art date
Application number
SG11201706693QA
Other languages
English (en)
Inventor
Saez Joan Carlos Arce
Jane Ruman
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of SG11201706693QA publication Critical patent/SG11201706693QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
SG11201706693QA 2015-02-26 2016-02-25 Methods of treating infertility SG11201706693QA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562121113P 2015-02-26 2015-02-26
US201562121131P 2015-02-26 2015-02-26
EP15157661 2015-03-04
EP15185191 2015-09-15
PCT/EP2016/053934 WO2016135221A1 (fr) 2015-02-26 2016-02-25 Procédés de traitement de l'infertilité

Publications (1)

Publication Number Publication Date
SG11201706693QA true SG11201706693QA (en) 2017-09-28

Family

ID=56787937

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706693QA SG11201706693QA (en) 2015-02-26 2016-02-25 Methods of treating infertility

Country Status (25)

Country Link
US (4) US10413592B2 (fr)
EP (2) EP4289477A3 (fr)
JP (2) JP7163027B2 (fr)
KR (1) KR102618298B1 (fr)
CN (2) CN113769069A (fr)
AU (1) AU2016223496B2 (fr)
CA (1) CA2976032A1 (fr)
DK (1) DK3261661T3 (fr)
ES (1) ES2968102T3 (fr)
FI (1) FI3261661T3 (fr)
HK (1) HK1246655A1 (fr)
HR (1) HRP20240013T1 (fr)
HU (1) HUE064604T2 (fr)
LT (1) LT3261661T (fr)
MA (1) MA41758B1 (fr)
MD (1) MD3261661T2 (fr)
MX (1) MX2017010320A (fr)
PH (1) PH12017501493A1 (fr)
PL (1) PL3261661T3 (fr)
RS (1) RS65096B1 (fr)
RU (1) RU2723098C2 (fr)
SG (1) SG11201706693QA (fr)
SI (1) SI3261661T1 (fr)
WO (1) WO2016135221A1 (fr)
ZA (1) ZA201705489B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201706693QA (en) 2015-02-26 2017-09-28 Ferring Bv Methods of treating infertility
EP3973982B1 (fr) 2017-09-01 2024-07-31 Ferring B.V. Composition de stimulation ovarienne contrôlée
CN109602394B (zh) * 2018-12-12 2020-01-17 北京大学第三医院 评估受试者卵巢储备功能的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
EP3932419A1 (fr) * 2020-06-29 2022-01-05 Ferring B.V. Procédés de traitement de la stérilité
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
AU2020454716A1 (en) * 2020-06-26 2023-01-19 Ferring B.V. HP-hMG for use in the treatment of infertility in a patient with Polycystic Ovary Syndrome
KR102498267B1 (ko) 2021-01-13 2023-02-13 주식회사 아이웍스 마이크로버블 생성 혼합 수중 에어레이터 회전분사 조립체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
CA2370225C (fr) 1999-04-16 2010-06-29 Instituto Massone S.A. Compositions de gonadotrophines extremement purifiees et leur procede de preparation
IL160782A0 (en) * 2001-09-12 2004-08-31 Applied Research Systems USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
US20140235540A1 (en) * 2008-05-20 2014-08-21 Norbert Gleicher Androgen and gonadotropin treatment in females
RU2466724C1 (ru) * 2011-05-31 2012-11-20 Фатима Якубовна Богатырева Способ лечения больных бесплодием, обусловленным поликистозом яичников, яичникового генеза на фоне хронического и острого воспаления органов малого таза
US9404908B2 (en) * 2013-04-29 2016-08-02 The Board of Truestees of the Leland Stanford Junior University Non-invasive imaging to the blastocyst stage for the detection of human embryonic aneuploidy
SG11201706693QA (en) 2015-02-26 2017-09-28 Ferring Bv Methods of treating infertility

Also Published As

Publication number Publication date
FI3261661T3 (fi) 2024-01-15
US20200093893A1 (en) 2020-03-26
RS65096B1 (sr) 2024-02-29
EP3261661B1 (fr) 2023-10-18
CA2976032A1 (fr) 2016-09-01
WO2016135221A1 (fr) 2016-09-01
PH12017501493A1 (en) 2018-01-29
HK1246655A1 (zh) 2018-09-14
CN113769069A (zh) 2021-12-10
RU2017131129A3 (fr) 2019-07-17
JP7157108B2 (ja) 2022-10-19
US20160250296A1 (en) 2016-09-01
PL3261661T3 (pl) 2024-03-25
SI3261661T1 (sl) 2024-03-29
MA41758A (fr) 2018-01-03
EP4289477A2 (fr) 2023-12-13
ZA201705489B (en) 2024-02-28
CN107257690A (zh) 2017-10-17
AU2016223496A1 (en) 2017-08-10
ES2968102T3 (es) 2024-05-07
DK3261661T3 (da) 2024-01-15
JP2018511575A (ja) 2018-04-26
MX2017010320A (es) 2018-01-23
US11351228B2 (en) 2022-06-07
MA41758B1 (fr) 2024-03-29
JP7163027B2 (ja) 2022-10-31
KR102618298B1 (ko) 2023-12-26
HRP20240013T1 (hr) 2024-03-29
RU2723098C2 (ru) 2020-06-08
KR20170123321A (ko) 2017-11-07
LT3261661T (lt) 2024-01-25
AU2016223496B2 (en) 2021-09-09
US11679145B2 (en) 2023-06-20
US10413592B2 (en) 2019-09-17
HUE064604T2 (hu) 2024-04-28
MD3261661T2 (ro) 2024-04-30
US20240009278A1 (en) 2024-01-11
US20210093697A1 (en) 2021-04-01
JP2020203904A (ja) 2020-12-24
EP4289477A3 (fr) 2024-02-21
EP3261661A1 (fr) 2018-01-03
RU2017131129A (ru) 2019-03-28

Similar Documents

Publication Publication Date Title
HK1251409A1 (zh) 治療癌症的方法
IL260199B (en) Cancer treatment methods
IL285151A (en) Methods for the treatment of fgf21-related disorders
IL281293A (en) Methods of treating hyperalgesia
HK1244217A1 (zh) 用於治療蛋白質病的方法
HK1246655A1 (zh) 治療不育的方法
IL256207B (en) Methods for treating multiple sclerosis
IL265696A (en) Methods for treating female infertility
GB201410116D0 (en) Method of treatment
HK1247818A1 (zh) 治療疾病的方法
IL253028A0 (en) treatment method
HUE048757T2 (hu) FSH meddõség kezelésére
GB201904142D0 (en) Improved method of FT-IMS
GB201602802D0 (en) Method of treatment
HK1243937A1 (zh) 治療疾病的方法
GB201512139D0 (en) Methods of treatment
PT3261661T (pt) Menotropina para tratar a infertilidade
GB201511017D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201421980D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment